logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jesús Herránz

geicam
H指数:27
被引数:2,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trop-2 overexpression as a prognostic marker in early triple-negative breast cancer: results from the GEICAM_CIBOMA trial

Trop-2过表达作为早期三阴性乳腺癌的预后标志物：GEICAM_CIBOMA试验的结果

Breast Cancer Research
IF5.6
2026-08-280
OA
Federico Rojo; Sara Lopez-Tarruella; Begoña Bermejo; Laura Torrecillas; Manuel Ruiz-Borrego; Jose Bines; Jose G. M. Segalla; Jose A. Garcia-Saenz; Roberto Torres; Juan de la Haba-Rodriguez; Elena Garcia-Martinez; Henry Gomez; Antonio Llombart-Cussac; Maria Rodriguez de la Borbolla; Laura Perez Michel; Margarita Amenedo; Isaura Fernandez; Alvaro Rodriguez-Lescure; Jesus Cardenas; Jeferson Vinholes; Eduardo Martinez de Dueñas; Vega Iranzo Gonzalez-Cruz; Miguel Angel Segui; Sandra Perez-Buira; Jesus Herranz; Raul Rincon; Rosalia Caballero; Carlos H. Barrios; Miguel Martin; Angel Guerrero-Zotano
Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials

中间终点作为长期结局的替代指标在乳腺癌辅助化疗试验中的应用

ONCOLOGIST
IF4.2
2025-09-010
OAAI
Blasco, Andrea; Lopez-Tarruella, Sara; Urruticoechea, Ander; Carrasco, Eva; Spera, Gonzalo; Martin, Miguel; Bermejo, Begona; Chap, Linnea; Ruiz-Borrego, Manuel; Crown, John; Garcia-Saenz, Jose A.; Chan, Arlene; Guerrero-Zotano, Angel; Semiglazov, Vladimir; Calvo, Lourdes; Pienkowski, Tadeusz; Herranz, Jesus; Slamon, Dennis
Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies

回顾性分析以验证El Álamo IV登记研究和GEICAM辅助研究中患者的CTS5。

ONCOLOGIST
IF4.2
2025-04-040
OA
Lopez-Tarruella, Sara; Pollan, Marina; Carrasco, Eva; Andres, Raquel; Martin, Miguel; Servitja, Sonia; Bermejo, Begona; Anton, Antonio; Guerrero-Zotano, Angel; Munoz, Montserrat; Fernandez, Luis; del Prado, Purificacion Martinez; Alvarez, Isabel; Calvo, Lourdes; Rodriguez-Lescure, Alvaro; Marin, Maria; Ruiz-Borrego, Manuel; Herranz, Jesus; Polonio, Oscar; Adrover, Encarna; Moreno, Diana
Gestational breast cancer: distinctive molecular and clinico-epidemiological features
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
IF3.6
2024-11-081
OAAI
de la Haba-Rodriguez, J. R.; Minguez, P.; Rojo, F.; Martin, M.; Alba, E.; Servitja, S.; Prat, A.; Perez-Fidalgo, J. A.; Gavila, J.; Morales, C.; Rodriguez-Lescure, A.; Herrero, C.; Pena-Enriquez, R.; Herranz, J.; Hernando, C.; Hernandez-Blanquisett, A.; Guil-Luna, S.; Martinez, M. T.; Blanch, S.; Caballero, R.; Martin, N.; Pollan, M.; Guerrero-Zotano, A.; Bermejo, B.
Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays

GEICAM/2011-06试验中HER2-low乳腺癌的患病率：标准化免疫组化检测在HER2-low分类上的一致性

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Rojo, F.; Calvo-Martinez, L.; Bermejo, B.; Bernet, L.; Burgues, O.; Garcia-Caballero, T.; Lopez-Tarruella Cobo, S.; Perez, S.; Antolin-Novoa, S.; Cejalvo, J. M.; Jerez Gilarranz, Y.; Morales Estevez, C.; Reboredo Rendo, C.; Martinez, M. T. M.; Herranz, J.; Rincon Sanchez, R.; Caballero, R.; Barnadas, A.; De la Haba Rodriguez, J.; Martin Jimenez, M.
Lower pre-treatment B-cell gene expression signatures correspond with improved overall survival with palbociclib plus endocrine therapy in HR+/HER2-metastatic breast cancer: a biomarker analysis from the GEICAM/2013-02 PEARL trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Agrawal, Yash; Fernandez-Martinez, Aranzazu; Gil-Gil, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Ciruelos, Eva; Munoz, Montserrat; Margeli, Mireia; Bermejo, Begona; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Alonso-Romero, Jose L.; Garcia-Saenz, Jose Angel; Sanchez-Rovira, Pedro; Alvarez, Elena; Chacon, J. Ignacio; Gonzalez-Santiago, Santiago; Rodriguez, Cesar A.; Servitja, Sonia; Pfefferle, Adam D.; Herranz, Jesus; Liu, Yuan; Carey, Lisa A.; Romero-Camarero, Isabel; Caballero, Rosalia; Perou, Charles M.; Martin, Miguel
Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity
NATURE COMMUNICATIONS
IF15.7
2022-09-2715
OAAI
Barradas, Marta; Plaza, Adrian; Colmenarejo, Gonzalo; Lazaro, Iolanda; Costa-Machado, Luis Filipe; Martin-Hernandez, Roberto; Mico, Victor; Lopez-Aceituno, Jose Luis; Herranz, Jesus; Pantoja, Cristina; Tejero, Hector; Diaz-Ruiz, Alberto; Al-Shahrour, Fatima; Daimiel, Lidia; Loria-Kohen, Viviana; de Molina, Ana Ramirez; Efeyan, Alejo; Serrano, Manuel; Pozo, Oscar J.; Sala-Vila, Aleix; Fernandez-Marcos, Pablo J.
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
FRONTIERS IN ONCOLOGY
IF3.3
2022-02-1110
OAAI
Ocana, Alberto; Chacon, Jose Ignacio; Calvo, Lourdes; Anton, Antonio; Mansutti, Mauro; Albanell, Joan; Martinez, Maria Teresa; Lahuerta, Ainhara; Bisagni, Giancarlo; Bermejo, Begona; Semiglazov, Vladimir; Thill, Marc; Chan, Arlene; Morales, Serafin; Herranz, Jesus; Tusquets, Ignacio; Chiesa, Massimo; Caballero, Rosalia; Valagussa, Pinuccia; Bianchini, Giampaolo; Alba, Emilio; Gianni, Luca
Identification of a specific epigenetic signature in patients showing secondary hypertension upon anti-VEGF treatment from the GEICAM/2011-04 (BRECOL) study
CANCER RESEARCH
IF16.6
2020-02-150
PRE
de la Haba, Juan; Morales-Ruiz, Teresa; Garcia-Alfonso, Pilar; Ponce Lorenzo, Jose; Calvo, Lourdes; Anton, Antonio; Marquez, Raul; Sanchez-Rovira, Pedro; Santaballa, Ana; Ciruelos, Eva; Garcia-Ortiz, Maria Victoria; Roldan-Arjona, Teresa; Herranz, Jesus; Chiesa, Massimo; Caballero, Rosalia; Gallego, Javier; Rodriguez-Lescure, Alvaro
Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer

将PAM50基因表达重新解释为定量肿瘤维度显示了临床试验的实用性: 在乳腺癌的预后和对紫杉醇的反应中的应用

BREAST CANCER RESEARCH AND TREATMENT
IF3
2019-01-2310
OAAI
Camp, Nicola J.; Madsen, Michael J.; Herranz, Jesus; Rodriguez-Lescure, Alvaro; Ruiz, Amparo; Martin, Miguel; Bernard, Philip S.

研究方向

暂未获取到该数据
A
Ana Ramı́rez de Molina
H 指数:43论文数:253被引数:6,283
R
Rosalía Caballero
H 指数:26论文数:241被引数:3,873
G
Guillermo Reglero
H 指数:60论文数:354被引数:1.2万
B
Begoña Bermejo
H 指数:41论文数:635被引数:6,660
L
Lourdes Calvo
H 指数:37论文数:241被引数:6,019
S
Susana Molina
H 指数:22论文数:77被引数:1,643
M
Miguel Martín
H 指数:107论文数:1,252被引数:4.6万
S
Sara López‐Tarruella
H 指数:28论文数:249被引数:2,747
J
Jaime Feliú
H 指数:44论文数:459被引数:7,250
Á
Álvaro Rodríguez-Lescure
H 指数:29论文数:143被引数:4,622